BioMarin Pharmaceutical
BMRN
#1907
Rank
S$13.29 B
Marketcap
S$69.20
Share price
-0.78%
Change (1 day)
-21.86%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$2.01 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are S$2.01 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$1.80 B-27.52%
2023-12-31S$2.49 B5.08%
2022-12-31S$2.37 B1.03%
2021-12-31S$2.35 B2.02%
2020-12-31S$2.30 B9.04%
2019-12-31S$2.11 B6.02%
2018-12-31S$1.99 B-18.31%
2017-12-31S$2.44 B34.09%
2016-12-31S$1.81 B-3.16%
2015-12-31S$1.87 B50.1%
2014-12-31S$1.25 B9.43%
2013-12-31S$1.14 B69.31%
2012-12-31S$0.67 B-2.04%
2011-12-31S$0.68 B-1.8%
2010-12-31S$0.70 B-15.9%
2009-12-31S$0.83 B-7.29%
2008-12-31S$0.90 B-0.23%
2007-12-31S$0.90 B70.39%
2006-12-31S$0.52 B16.7%
2005-12-31S$0.45 B-7.5%
2004-12-31S$0.49 B108.66%
2003-12-31S$0.23 B1023.18%
2002-12-31S$20.94 M-7.72%
2001-12-31S$22.7 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$1.52 B-24.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.10 B-94.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.05 B-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$85.56 B 4,137.50%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
S$0.82 B-59.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$0.17 B-91.57%๐Ÿ‡บ๐Ÿ‡ธ USA